Announcements

MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.

The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.

About Professor Michele Parrinello

"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”

——Professor Michele Parrinello

Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies.

For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.

Award Committee

The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process. The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award.

"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."

——Professor Xin-Gao Gong

The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.

About the MDPI Sustainability Foundation and MDPI Awards

The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields. 

In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.

Find more information on awards here.

We are honored to recognize the 2024 MDPI Top 1000 Reviewers—scholars whose exemplary commitment to rigorous and constructive peer review is vital in upholding the highest standards of academic publishing.

Selected from a distinguished pool of 215,000 reviewers from 65 countries and regions worldwide, these honorees stand out for their exceptional expertise, diligence, and dedication to advancing research through timely and thoughtful reviews. Their constructive and impartial feedback ensures the publication of high-quality, impactful research, while their timely reviews facilitate swift revisions and faster publication of innovative work.

Peer review is the invisible foundation of academic progress. With gratitude and respect, we celebrate these 1000 scholars who made that foundation stronger in 2024. We respected all privacy preferences, with part of nominees opting for limited attribution.

The names of these reviewers are listed below in alphabetical order by first name:

The endocrine system acts as the body's “command center”, and its dysfunction can lead to a variety of endocrine diseases, which have become a global health challenge. We would like to invite you to read our collection of highly cited papers on endocrine diseases published in Journal of Clinical Medicine (JCM, ISSN: 2077-0383). We hope they provide useful insights for researchers in selecting treatment options and developing health management strategies. Moreover, several hot topic Special Issues pertaining to this topic are currently open for submissions.

1. “The Lipid Accumulation Product Index (LAP) and the Cardiometabolic Index (CMI) Are Useful for Predicting the Presence and Severity of Metabolic Syndrome in Adult Patients with Obesity”
by Sofia Tamini, Adele Bondesan, Diana Caroli and Alessandro Sartorio
J. Clin. Med. 2024, 13(10), 2843; https://doi.org/10.3390/jcm13102843
Full text available online: https://www.mdpi.com/2077-0383/13/10/2843

2. “Pituitary Apoplexy: An Updated Review”
by Pedro Iglesias
J. Clin. Med. 2024, 13(9), 2508; https://doi.org/10.3390/jcm13092508
Full text available online: https://www.mdpi.com/2077-0383/13/9/2508

3. “Complete Blood Count (CBC)-Derived Inflammation Indexes Are Useful in Predicting Metabolic Syndrome in Adults with Severe Obesity”
by Alice Marra, Adele Bondesan, Diana Caroli and Alessandro Sartorio
J. Clin. Med. 2024, 13(5), 1353; https://doi.org/10.3390/jcm13051353
Full text available online: https://www.mdpi.com/2077-0383/13/5/1353

4. “Interactions between the Exocrine and the Endocrine Pancreas”
by Roberto Valente, Alessandro Coppola, Chiara Maria Scandavini, Asif Halimi, Annelie Magnusson, Augusto Lauro, Ira Sotirova, Urban Arnelo and Oskar Franklin
J. Clin. Med. 2024, 13(4), 1179; https://doi.org/10.3390/jcm13041179
Full text available online: https://www.mdpi.com/2077-0383/13/4/1179

5. “Barriers to Type 1 Diabetes Adherence in Adolescents”
by Sarah Azar, Noa Maroun Abou Jaoude, Andrzej Kędzia and Elżbieta Niechciał
J. Clin. Med. 2024, 13(19), 5669; https://doi.org/10.3390/jcm13195669
Full text available online: https://www.mdpi.com/2077-0383/13/19/5669

6. “Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis”
by Mark Ayoub, Harleen Chela, Nisar Amin, Roberta Hunter, Javaria Anwar, Veysel Tahan and Ebubekir Daglilar
J. Clin. Med. 2025, 14(3), 944; https://doi.org/10.3390/jcm14030944
Full text available online: https://www.mdpi.com/2077-0383/14/3/944

7. “Challenges of Managing Type 3c Diabetes in the Context of Pancreatic Resection, Cancer and Trauma”
by Colton D. Wayne, Chahrazed Benbetka, Gail E. Besner and Siddharth Narayanan
J. Clin. Med. 2024, 13(10), 2993; https://doi.org/10.3390/jcm13102993
Full text available online: https://www.mdpi.com/2077-0383/13/10/2993

8. “Impact of Concurrent Exercise Training on Cardiac Autonomic Modulation, Metabolic Profile, Body Composition, Cardiorespiratory Fitness, and Quality of Life in Type 2 Diabetes with Cardiac Autonomic Neuropathy: A Randomized Controlled Trial”
by Saima Zaki, Md Farhan Alam, Saurabh Sharma, Said El-Ashker, Mohammad Ahsan and Shibili Nuhmani.
J. Clin. Med. 2024, 13(13), 3910; https://doi.org/10.3390/jcm13133910
Full text available online: https://www.mdpi.com/2077-0383/13/13/3910

9. “Early-Onset Colorectal Cancer: Are Neuroendocrine Tumors or Adenocarcinomas the Culprit? Analysis of the Largest U.S. Cancer Incidence Database, 2001–2020”
by Yazan Abboud, Madison Fraser, Imran Qureshi and Kaveh Hajifathalian
J. Clin. Med. 2024, 13(4), 1098; https://doi.org/10.3390/jcm13041098
Full text available online: https://www.mdpi.com/2077-0383/13/4/1098

10. “Adrenal Cysts: To Operate or Not to Operate?”
by Ivana Bozic Antic, Igor Djurisic and Srdjan Nikolic
J. Clin. Med. 2024, 13(3), 846; https://doi.org/10.3390/jcm13030846
Full text available online: https://www.mdpi.com/2077-0383/13/3/846

Special Issues:
“Chronic Complications of Type 2 Diabetes: Prevalence, Prevention, and Management” Guest Editor: Dr. Ilias Migdalis Submission deadline: 20 January 2026	“Neuroendocrine Tumors: Challenges and Future Perspectives (Second Edition) ” Guest Editors: Dr. Anna La Salvia Dr. Giuseppe Lamberti Submission deadline: 20 February 2026
“New Advances and Clinical Outcomes of Pediatric Endocrinology” Guest Editor: Dr. Gerdi Tuli Submission deadline: 28 February 2026	“Recent Advances in Endocrine Surgery—2nd Edition” Guest Editor: Dr. Gregorio Scerrino Submission deadline: 20 April 2026

World Cervical Cancer Elimination Day is an annual observance aimed at enhancing awareness of cervical cancer prevention and treatment, fostering a deeper recognition of the urgency to eliminate the disease, while also drawing attention to the global health burden it imposes—especially on women’s well-being. This day highlights the pivotal role that collective action plays in advancing cervical cancer screening, vaccination, and access to care, thereby reinforcing the imperative for its elimination. Under the theme “Act Now: Eliminate Cervical Cancer”, calls for bold, united action to build on existing progress and accelerate impact toward the 90-70-90 targets by 2030.

“Progress and Challenges in Canada’s Path Toward the Elimination of Cervical Cancer”
by Samara Perez
Curr. Oncol. 2024, 31(10), 5850-5861; https://doi.org/10.3390/curroncol31100435

“High-Risk HPV Screening Initiative in Kosovo—A Way to Optimize HPV Vaccination for Cervical Cancer”
by Jessica L. Bentz, Rachael E. Barney, Natalia Georgantzoglou, Suzana Manxhuka-Kerliu et al.
Diseases 2024, 12(8), 189; https://doi.org/10.3390/diseases12080189

“Cervical Cancer Genetic Profile through Circulating Tumor DNA: What Can We Learn from Blood?”
by Sevastiani Antonouli, Valentina Di Nisio, Nikoletta Daponte, Athina-Ioanna Daponte and Alexandros Daponte
Biomolecules 2024, 14(7), 825; https://doi.org/10.3390/biom14070825

“An Epidemiological Study of Cervical Cancer Trends among Women with Human Immunodeficiency Virus”
by Arlesia Mathis, Ukamaka D. Smith, Vanessa Crowther, Torhonda Lee and Sandra Suther
Healthcare 2024, 12(12), 1178; https://doi.org/10.3390/healthcare12121178

“Artificial Intelligence and Colposcopy: Automatic Identification of Cervical Squamous Cell Carcinoma Precursors”
by Miguel Mascarenhas, Inês Alencoão, Maria João Carinhas, Miguel Martins, Pedro Cardoso, Francisco Mendes, Joana Fernandes, João Ferreira, Guilherme Macedo and Rosa Zulmira Macedo
J. Clin. Med. 2024, 13(10), 3003; https://doi.org/10.3390/jcm13103003

“Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022”
by Marie Rykkelid, Helga Marie Wennberg, Elin Richardsen and Sveinung Wergeland Sørbye
Pathogens 2024, 13(5), 381; https://doi.org/10.3390/pathogens13050381

“Identification and Validation of eRNA as a Prognostic Indicator for Cervical Cancer”
by Lijing Huang, Jingkai Zhang, Zhou Songyang and Yuanyan Xiong
Biology 2024, 13(4), 227; https://doi.org/10.3390/biology13040227

“Cervical Cancer Associated with Pregnancy: Current Challenges and Future Strategies”
by Jennifer Le Guévelou, Lise Selleret, Enora Laas, Fabrice Lecuru and Manon Kissel
Cancers 2024, 16(7), 1341; https://doi.org/10.3390/cancers16071341

“Correlation of the HPV 16 Genotype Persistence in Women Undergoing LEEP for CIN3 with the Risk of CIN2+ Relapses in the First 18 Months of Follow-Up: A Multicenter Retrospective Study”
by Maria Teresa Bruno, Gaetano Valenti, Zaira Ruggeri, Giosuè Giordano Incognito, Paola Coretti, Giuseppe Dario Montana, Marco Marzio Panella and Liliana Mereu
Diagnostics 2024, 14(5), 509; https://doi.org/10.3390/diagnostics14050509

“Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma”
by Jialu Li and Juqun Xi
Genes 2024, 15(1), 121; https://doi.org/10.3390/genes15010121

“Pain in High-Dose-Rate Brachytherapy for Cervical Cancer: A Retrospective Cohort Study”
by Ángel Becerra-Bolaños, Miriam Jiménez-Gil, Mario Federico, Yurena Domínguez-Díaz, Lucía Valencia and Aurelio Rodríguez-Pérez
J. Pers. Med. 2023, 13(8), 1187; https://doi.org/10.3390/jpm13081187

	“Viral Infections, Chronic Inflammation and Carcinogenesis” Guest Editors: Dr. Angioletta Lasagna and Dr. Davide Dalu Submission deadline: 15 February 2026
	“Clinical Management of Cervical Cancer” Guest Editor: Dr. Vanessa Samouëlian Submission deadline: 31 March 2026
	“HPV Vaccine and Cervical Cancer Prevention” Guest Editor: Dr. Andreia Cristina de Melo Submission deadline: 30 April 2026
	“Recent Advances and Strategies for the Management of CIN and HPV Eradication Starategies for the Prevention of Uterine Cervical Cancer” Guest Editor: Dr. Masaru Sakamoto Submission deadline 30 April 2026

World Diabetes Day will take place on 14 November 2025, under the theme “Diabetes and well-being”. Diabetes is a major cause of blindness, kidney failure, heart attack, stroke and lower limb amputation. A healthy diet, physical activity and avoiding tobacco use can prevent or delay type 2 diabetes. In addition, diabetes can be treated and its consequences avoided or delayed with medication, regular screening and treatment for complications.

In recognition of this important day, we recommend the following related articles, Special Issues and journals spanning multidisciplinary fields, including clinical medicine, biology and material sciences. We believe th.at promoting such research contributes to enhanced public awareness of innovative ideas regarding the prevention, treatment and care of diabetes. This World Diabetes Day, 14 November, let us put well-being at the heart of diabetes care and start the change for a better life with diabetes.

“New-Onset Diabetes After Transplantation in Renal Recipients: A Pilot Comparative Study of Immediate vs. Extended-Release Tacrolimus Formulation”
by Ioana Adela Ratiu, Florin Bănică, Corina Moisa, Bianca Pașca, Daniela Gîtea, Iulia Dana Grosu, Gabriel Cristian Bako, Oliviu Voștinaru, Wael Abu Dayyih and Lorena Filip
Pharmaceuticals 2025, 18(10), 1532; https://doi.org/10.3390/ph18101532

“From Current Therapeutics to Multitarget Ligands: A Review of Diabetes Pharmacological Treatments”
by Francesc Cabré, Josep J. Centelles and Marta Cascante
Pharmaceutics 2025, 17(9), 1125; https://doi.org/10.3390/pharmaceutics17091125

“Impact of Antidiabetic Medication on Therapy Outcomes in Metastatic Urothelial Cancer Patients Receiving Enfortumab Vedotin Monotherapy”
by Laila Schneidewind, Bernhard Kiss, Friedemann Zengerling, Annemarie Uhlig, Niklas Klümper, Thomas Büttner, Julia Heinzelbecker, Thomas Elegeert, Cem Aksoy, Cindy Rönnau et al.
Biologics 2025, 5(3), 20; https://doi.org/10.3390/biologics5030020

“Gene–Diet Interactions in Diabetes Mellitus: Current Insights and the Potential of Personalized Nutrition”
by Angeliki Kapellou, Effie Salata, Dimitrios Miltiadis Vrachnos, Sevastiani Papailia and Spiros Vittas
Genes 2025, 16(5), 578; https://doi.org/10.3390/genes16050578

“Anti-Diabetic Therapies and Cancer: From Bench to Bedside”
by Dimitris Kounatidis, Natalia G. Vallianou, Irene Karampela, Eleni Rebelos, Marina Kouveletsou, Vasileios Dalopoulos, Petros Koufopoulos, Evanthia Diakoumopoulou, Nikolaos Tentolouris and Maria Dalamaga
Biomolecules 2024, 14(11), 1479; https://doi.org/10.3390/biom14111479

“Untargeted and Targeted Lipidomics Unveil Dynamic Lipid Metabolism Alterations in Type 2 Diabetes”
by Li Feng, Bingshu He, Jianzhen Xia and Zhonghua Wang
Metabolites 2024, 14(11), 610; https://doi.org/10.3390/metabo14110610

“Quality of Dietetic Patient Education Materials for Diabetes and Gastrointestinal Disorders: Where Can We Do Better?”
by Kelly Lambert, Olivia Hodgson and Claudia Goodman
Dietetics 2024, 3(3), 346-356; https://doi.org/10.3390/dietetics3030026

“Biomaterials Designed to Modulate Reactive Oxygen Species for Enhanced Bone Regeneration in Diabetic Conditions”
by Mingshan Li, Zhihe Zhao and Jianru Yi
J. Funct. Biomater. 2024, 15(8), 220; https://doi.org/10.3390/jfb15080220

“The Interrelationship between Diabetes Mellitus and Emotional Well-Being: Current Concepts and Future Prospects”
by Polyxeni Mangoulia, Charalampos Milionis, Eugenia Vlachou and Ioannis Ilias
Healthcare 2024, 12(14), 1457; https://doi.org/10.3390/healthcare12141457

“Are Hyperglycemia-Induced Changes in the Retina Associated with Diabetes-Correlated Changes in the Brain? A Review from Zebrafish and Rodent Type 2 Diabetes Models”
by Kaylee Augustine-Wofford, Victoria P. Connaughton and Elizabeth McCarthy
Biology 2024, 13(7), 477; https://doi.org/10.3390/biology13070477

“Interleukin-6 as a Director of Immunological Events and Tissue Regenerative Capacity in Hemodialyzed Diabetes Patients”
by Maria-Florina Trandafir, Octavian Savu, Daniela Pasarica, Coralia Bleotu and Mihaela Gheorghiu
Med. Sci. 2024, 12(2), 31; https://doi.org/10.3390/medsci12020031

“Euonymus alatus Extract Reduces Insulin Resistance in db/db Mice by Regulating the PI3K–AKT Pathway”
by Seoung-Uk. Lee, Pallavi Gurung, Til Bahadur Thapa Magar, Junmo Lim, Rajeev Shrestha, Yoon-Hee Kim and Yong-Wan Kim
Int. J. Transl. Med. 2024, 4(2), 286-297; https://doi.org/10.3390/ijtm4020018

“Personalized Diabetes Management with Digital Twins: A Patient-Centric Knowledge Graph Approach”
by Fatemeh Sarani Rad, Rasha Hendawi, Xinyi Yang and Juan Li
J. Pers. Med. 2024, 14(4), 359; https://doi.org/10.3390/jpm14040359

“NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay”
by Simona Cernea
Life 2024, 14(2), 272; https://doi.org/10.3390/life14020272

“Mitochondrial Dysfunction in Diabetes: Shedding Light on a Widespread Oversight”
by Franklyn Nonso Iheagwam, Amarachi Joy Joseph, Eniola Deborah Adedoyin, Olawumi Toyin Iheagwam and Samuel Akpoyowvare Ejoh
Pathophysiology 2025, 32(1), 9; https://doi.org/10.3390/pathophysiology32010009

“Is Tirzepatide the New Game Changer in Type 2 Diabetes?”
by Giuseppe Lisco, Olga Eugenia Disoteo, Vincenzo De Geronimo, Anna De Tullio, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Emilio Jirillo and Vincenzo Triggiani
Endocrines 2024, 5(1), 72-86; https://doi.org/10.3390/endocrines5010005

“Fostering Resilience and Wellness: The Synergy of Mindful Eating and the Mediterranean Lifestyle”
by Efstratios Christodoulou, Georgia-Eirini Deligiannidou, Christos Kontogiorgis, Constantinos Giaginis and Antonios E. Koutelidakis
Appl. Biosci. 2024, 3(1), 59-70; https://doi.org/10.3390/applbiosci3010004

“The Main Risk Factors in Type 2 Diabetes for Cognitive Dysfunction, Depression, and Psychosocial Problems: A Systematic Review”
by Maarja Randväli, Toomas Toomsoo and Jekaterina Šteinmiller
Diabetology 2024, 5(1), 40-59; https://doi.org/10.3390/diabetology5010004

“Chronic Kidney Disease in the Older Adult Patient with Diabetes”
by Raja Ravender, Maria-Eleni Roumelioti, Darren W. Schmidt, Mark L. Unruh and Christos Argyropoulos
J. Clin. Med. 2024, 13(2), 348; https://doi.org/10.3390/jcm13020348

World Children’s Day was first established in 1954 as Universal Children’s Day and is celebrated on 20 November each year to promote international co-operation, awareness among children worldwide, and improvements in their welfare. This year, under the theme “Listen to the Future, Stand up for Children’s Rights”, we were honored to interview Dr. Anna Di Sessa, a Section Board Member of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383).

The following is a short interview with Dr. Anna Di Sessa:

1. Could you introduce yourself and share a brief overview of your research field?
I am a pediatrician with a specialized focus on endocrinology and nephrology, currently practicing at the Pediatric Clinic of the University of Campania “Luigi Vanvitelli”. In January 2020, I earned a PhD in translational medicine from the same institution. Since 2011, my research has primarily concentrated on childhood obesity and its cardiometabolic consequences, particularly focusing on metabolic dysfunction-associated steatotic liver disease (MASLD) and kidney damage. 

2. What is the biggest challenge you have faced in your research career?
One of the key challenges I have faced was bridging the gap between research findings and their practical application in clinical settings. In pediatrics, while new treatments or interventions may demonstrate promising results in clinical trials, translating these findings into routine practice often encounters significant barriers. These include limitations in healthcare infrastructure, cost considerations, and resistance to adopting new practices among clinicians.
Additionally, conducting research with vulnerable populations, such as children, introduces ethical complexities. Ensuring that studies adhere to high ethical standards while protecting participants’ well-being and privacy requires meticulous planning and ongoing ethical reflection.

3. What does World Children’s Day mean to you, both as a researcher and as a member of the global community?
World Children’s Day serves as a crucial reminder of our collective responsibility to safeguard and prioritize the health, rights, and well-being of children. As a researcher, it underscores the need to address the unique health challenges children face through evidence-based research. On a broader scale, it emphasizes the importance of creating a world where all children can thrive, free from poverty, violence, and neglect. It is both a call to advance research focused on child health and to advocate for policies that protect and empower children globally.

4. Looking ahead, what changes or advancements would you most like to see in the next 10 years to ensure a safer, healthier, and more equitable future for all children?
In the next decade, I hope to see substantial progress in pediatric care, particularly through the integration of personalized medicine. By tailoring treatments to a child’s unique genetic profile, environmental factors, and lifestyle, personalized medicine has the potential to substantially enhance the precision and efficacy of interventions, particularly for complex conditions such as rare diseases, cancers, and chronic illnesses. The broader adoption of telemedicine and AI-driven diagnostic tools could also improve access to care, especially in underserved regions. Furthermore, there should be a heightened focus on pediatric mental health, alongside the development of global policies that ensure universal access to quality education, clean water, nutrition, and protection from harm. These advancements hold the promise of fostering a safer, healthier, and more equitable future for children worldwide.

5. As a Section Board Member of JCM, could you share your experience with MDPI?
As a Section Board Member of JCM, my experience with MDPI has been highly productive and rewarding. MDPI offers a robust platform for open access publishing, ensuring a transparent and efficient peer-review process. Working with MDPI has allowed me to contribute to the strategic direction of the journal, particularly in advancing clinical medicine while maintaining rigorous research standards. The editorial support and global reach provided by MDPI have facilitated the rapid dissemination of research, especially in specialized fields such as pediatrics. Their commitment to innovation and quality has significantly enhanced the visibility and impact of JCM.

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held its Academic Editorial Board meeting at the EASD 2025 on 16 September 2025 in Vienna, Austria. Six Editorial Board Members attended. As a premier event for staying abreast of the latest advancements in diabetes research and practice, EASD 2025 provided an ideal platform for this engagement. During the conference, we met our Section Editor-in-Chief, Prof. Dr. Didac Mauricio, and other scholars with whom we have cooperated for many years. We look forward to reconnecting with you at future international conferences to explore opportunities for deeper collaboration. We invite you to revisit the wonderful highlights of this event.

At our booth, we received positive feedback from scholars, who expressed satisfaction with their collaboration with us and a willingness to continue working with us. We are pleased to share some photos taken with scholars at our booth.

From left to right: Prof. Dr. Didac Mauricio and Nemanja Perovic (MDPI); Nemanja Perovic (MDPI), Dr. Alfredo Caturano, and Silvija Seles (MDPI).

At the Academic Editorial Board meeting, we provided a brief overview of JCM’s basic information and played a journal-produced promotional video. This video highlighted JCM’s scope, academic achievements, and role in the academic publishing landscape. The following key highlights were discussed in the meeting: (1) To increase the Impact Factor of the journal, Members suggested revising the scope of the journal and its Sections and conducting an analysis of the Impact Factor “per Section”. (2) New proposals and suggestions for peer review models were discussed. (3) Members felt we should share the metrics of the journal’s rejection rate and the evolution of objective metrics that are proof of quality (indexing in major databases, IFs, CiteScore values, and the outreach of publications). (4) It was suggested that we should advertise the awards we are granting to researchers. (5) Numerous suggestions were proposed regarding external collaborations, such as partnering with major institutions, exploring conference sponsorships and collaborations with academic societies, and deepening cooperation with young scholars. (6) Views were exchanged on the use of AI tools in research, and we shared some information about MDPI's initiatives in this area. (7) Members expressed interest in our proposal to “assist them in organizing their events,” and we will explore possibilities for expanding our collaboration model in the future.

Attendee list of Academic Editorial Board Meeting (in no particular order):

• Prof. Dr. Heinrich Resch, Section Board Member, Academic Teaching Hospital of the University Vienna, School of Medicine, University Vienna, Austria;
• Prof. Dr. Catharina Chiari, Guest Editor, Department of Pediatric Orthopedics and Foot Surgery, Orthopedic Hospital Speising, Austria;
• Prof. Dr. Katrin Bekes, Guest Editor, Department of Pediatric Dentistry, Medical University of Vienna, Austria;
• Dr. Ilias Migdalis, Guest Editor, Director of Diabetes Centre, Lefkos Stavros Hospital, Greece;
• Prof. Dr. Vilma Urbančič-Rovan, Guest Editor, ¹ Department of Endocrinology, University Medical Centre, University of Ljubljana, Ljubljana, Slovenia; ² Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia;
• Dr. Elias K. Spanakis, Guest Editor, Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, USA.

In addition, to explore highly cited papers on the topic of diabetes, please click here. Do not miss our conference column, where you can find information about the journal’s conferences.

We look forward to our continued collaboration. We are happy to accept your suggestions and feedback, so please feel free to contact the JCM Editorial Office via email at jcm@mdpi.com.

On behalf of the Editors-in-Chief, Prof. Dr. Emmanuel Andrès and Prof. Dr. Kent Doi, we wish to acknowledge our Guest Editors who established Special Issues in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) by presenting an award to the Special Issues that will be closed in 2026. Three Special Issues will receive the award. The Special Issues will be selected after a thorough evaluation by the journal Award Committee, led by the Editor-in-Chief. 

Eligibility for the Award:

• Special Issues that will be closed in 2026;
• Special Issues with more than 15 published papers.

Selection criteria:
The Special Issues will be selected by the journal Award Committee according to the following criteria:

• The alignment of the Special Issues and their publications with the journal’s aim and scope;
• Number of papers published;
• The visibility and influence of the Special Issue, including citations, downloads, and overall engagement.

Prize:

• CHF 500;
• An opportunity to publish a paper free of charge in JCM after peer review;
• A certificate.

Number of winners: 3.

The winners will be announced on the journal website at the end of March 2027.

JCM Editorial Office

Conference: Pharmacology 2025
Date: 16–18 December 2025
Location: Belfast, UK

MDPI will be attending Pharmacology 2025 as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.

The British Pharmacological Society’s annual “Pharmacology” conference brings together individuals from across academia, healthcare, industry and the regulatory sector to share and celebrate the latest research and developments in pharmacology and its related subject areas. The conference is a great opportunity for those studying and working to attend lectures from experts and emerging researchers, network and socialise, and showcase your own work.

The following open access journals will be represented:

• Future Pharmacology;
• Journal of Personalized Medicine;
• Journal of Clinical Medicine;
• Sclerosis;
• Scientia Pharmaceutica;
• Pharmacoepidemiology;
• Biomedicines;
• Psychoactives;
• Medicines;
• Journal of Pharmaceutical and BioTech Industry;
• Drugs and Drug Candidates.

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.miceconciergeme.com/pharmacology2025.

We are thrilled to share the updated Exceptional Reviewers List 2025. This program was designed to recognize and honor scholars who have delivered consistently exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. According to recent surveys conducted in 2024, 92% of our authors rate the peer review as good or excellent, thanks to our pool of excellent reviewers. 

We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in the journal’s peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable. 

The Exceptional Reviewers List was introduced in 2024. Each quarter we will be selecting a group of outstanding reviewers and announcing them here. 

Q3:

Name: Dr. Nagib Salloum Dahdah
Affiliation: CHU Sainte-Justine—Le centre hospitalier universitaire mere-enfant, Division of Pediatric Cardiology, Montreal, Canada
Interests: Kawasaki disease; pediatric cardiology, coronary revascularization 

Name: Dr. Chun-Hou Liao
Affiliation: Division of Urology, Department of Surgery, Cardinal Tien Hospital, Taipei, Taiwan College of Medicine, Fu-Jen Catholic University, Taipei, Taiwan
Interests: prostate cancer; urology 

Name: Dr. Andy Yen-Tung Teng
Affiliations: ¹ Center for Osteoimmunology and Biotechnology Research (COBR), School of Dentistry, College of Dental Medicine, Kaohsiung Medical University (KMU) & KMU-Hospital, Kaohsiung 80708, Taiwan; ² Laboratory of Molecular Microbial Immunity, Division of Periodontology, The Eastman Institute for Oral Health (EIOH), School of Medicine and Dentistry, University of Rochester, Rochester, NY 14620, USA
Interests: periodontology, oral microbiology, and immunology 

Name: Dr. Shona Goldsmith
Affiliation: Cerebral Palsy Alliance Research Institute, Discipline of Child and Adolescent Health, The University of Sydney, Sydney, Australia
Interests: cerebral palsy; child and adolescent health; physiotherapy 

Name: Dr. Romulo Leão S. Silva Neris
Affiliation: Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Interests: immunology; inflammation; viruses; virus infection 

Q2:

Name: Dr. Arieh Eden
Affiliation: Carmel Medical Center, Haifa, Israel
Interests: mechanical ventilation; critical care medicine; sepsis; anesthesiology 

Name: Dr. Frank-Mattias Schäfer
Affiliation: Department of Pediatric Surgery and Pediatric Urology, Cnopfsche Kinderklinik, Nürnberg, Germany
Interests: pediatric urology; pediatric surgery 

Name: Dr. Sveinung Wergeland Sørbye
Affiliation: Department of Clinical Pathology, University Hospital of North Norway, 9006 Tromsø, Norway
Interests: cancer immunology; prognostic markers; cervical cancer screening and prevention 

Name: Dr. Filipe Gonzalez
Affiliation: Critical Department, Hospital Garcia de Orta E.P.E, Almada, Portugal
Interests: hemodynamic monitoring; echocardiography; intensive care 

Name: Dr. Amanda J. Boyle
Affiliation: Centre for Addiction and Mental Health, Toronto, Canada
Interests: PET imaging; radiopharmaceuticals; neuroinflammatory; neurodegenerative diseases; oncology biomarkers 

Q1:

Name: Dr. Shehzad Rehman
Affiliation: OHSU School of Medicine, Portland, United States
Interests: nephrology and hypertension; transplantation

Name: Dr. Nicolas Johner
Affiliation: Cardiology Division, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, Switzerland
Interests: cardiology; atrial fibrillation; cardiac electrophysiology; electrocardiography; pacemakers 

Name: Dr. Matthew Bottomley
Affiliation: Oxford Kidney and Transplant Unit, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Interests: nephrology; immunological biomarker; organ transplant 

Name: Dr. Kristin Keller
Affiliation: Hospital Universitario 12 de Octubre, Madrid, Spain
Interests: nutrition and dietetics; abdominal obesity; metabolism 

Name: Dr. Masashi Mizuguchi
Affiliation: The University of Tokyo, Tokyo, Japan
Interests: child neurology; pediatrics; developmental neuroscience